Partial Victory For Pfizer In Xalatan Suit Vs. Par
Pfizer has won a partial victory in its patent infringement lawsuit against Par Pharmaceuticals over plans for a generic version of the glaucoma drug Xalatan (latanoprost)....To view the full article, register now.
Already a subscriber? Click here to view full article